https://birchbiomed.com/ubc-researchers-develop-drug-to-treat-scarring-and-autoimmune-diseases/2025-07-31T17:27:49-05:00https://birchbiomed.com/cknw-sean-leslie-show-fibrostop-a-drug-to-help-burn-victims/2025-07-31T16:51:20-05:00https://birchbiomed.com/ubc-develops-anti-scarring-drug/2025-07-31T19:26:18-05:00https://birchbiomed.com/birchbiomed-announces-completion-of-clinical-trial-for-ground-breaking-anti-scarring-drug/2025-07-31T17:28:46-05:00https://birchbiomed.com/birchbiomeds-scientific-advisory-board-member-dr-aziz-ghahary-is-the-2017-british-columbia-professional-fire-fighters-burn-fund-honouree/2025-07-31T16:49:22-05:00https://birchbiomed.com/sensus-healthcare-launches-collaboration-with-birchbiomed-to-treat-and-prevent-scarring-for-keloids-patients-around-the-world/2025-07-31T19:25:55-05:00https://birchbiomed.com/birchbiomed-is-cleared-to-begin-first-of-its-kind-phase-ii-clinical-trial-for-ground-breaking-anti-scarring-drug/2025-07-31T19:25:44-05:00https://birchbiomed.com/chairman-ceo-mark-miller-remarks-delivered-at-ceo-forum-at-south-beach-symposium-on-innovation-in-an-era-of-healthcare-upheaval/2025-07-31T19:25:33-05:00https://birchbiomed.com/qa-with-mark-s-miller-co-founder-chairman-and-ceo-of-birchbiomed-inc-developing-an-antifibrotic-therapeutic-for-the-prevention-of-scaring-and-breaking-down-existing-scars-and-an-autoimmune-platfo/2025-07-31T16:53:19-05:00https://birchbiomed.com/chief-science-officer-dr-ryan-hartwell-lecture-at-south-beach-symposium-on-the-latest-discoveries-and-innovations-in-fibrosis-research-notably-highlighting-published-data-from-birchbiomed-and-the/2025-07-31T19:25:16-05:00https://birchbiomed.com/sensus-healthcare-ceo-joseph-c-sardano-joins-birchbiomed-inc-board-of-directors/2025-07-31T19:25:04-05:00https://birchbiomed.com/birchbiomed-inc-to-present-at-the-11th-annual-ld-micro-main-event/2025-07-31T19:24:52-05:00https://birchbiomed.com/birchbiomed-to-highlight-fs2-platform-at-the-17th-annual-south-beach-symposium/2025-07-31T19:24:37-05:00https://birchbiomed.com/first-patient-enrolled-in-birchbiomeds-study-investigating-fs2-for-the-treatment-of-scars/2025-07-31T19:24:25-05:00https://birchbiomed.com/birchbiomed-issues-letter-to-shareholders/2025-07-31T19:24:14-05:00https://birchbiomed.com/birchbiomed-enrolls-first-patient-in-phase-ii-clinical-trial-of-its-unique-treatment-to-prevent-scarring/2025-07-31T19:24:03-05:00https://birchbiomed.com/birchbiomed-welcomes-renowned-dermatologist-to-its-board-of-directors/2025-07-31T19:23:38-05:00https://birchbiomed.com/birchbiomed-appoints-pharmaceutical-leader-and-global-affairs-expert-to-its-board-of-directors/2025-07-31T19:23:21-05:00https://birchbiomed.com/positive-topline-data-from-phase-2-study-of-fs2-for-treatment-of-keloid-scars/2025-07-31T19:23:09-05:00https://birchbiomed.com/birchbiomed-receives-health-canada-green-light-to-start-the-last-stage-of-its-groundbreaking-clinical-program-of-fs2-to-minimize-scarring-from-burns/2025-07-31T19:22:01-05:00https://birchbiomed.com/birchbiomed-welcomes-dr-carlos-roberto-camozzi-as-chief-medical-officer/2025-07-31T19:22:28-05:00https://birchbiomed.com/birchbiomed-welcomes-dr-jonathan-bourne-as-new-chief-science-officer/2025-07-31T19:22:51-05:00https://birchbiomed.com/birchbiomed-welcomes-herve-girsault-as-chief-business-officer/2025-07-31T19:22:39-05:00https://birchbiomed.com/innovation-in-treatment-of-keloid-scars/2025-07-31T17:02:09-05:00https://birchbiomed.com/birchbiomed-launches-pivitol-phase-ii-iii-pioneering-scar-treatment-trial-in-burns-with-hamilton-health-sciences-centre-for-burn-research-in-ontario/2026-01-23T10:10:38-05:00https://birchbiomed.com/bionexus-gene-lab-corp-signs-strategic-partnership-term-sheet-with-birchbiomed-inc/2026-01-23T10:10:32-05:00https://birchbiomed.com/hhs-centre-for-burn-research-leads-national-trial-for-scar-treatment/2026-01-23T10:10:27-05:00https://birchbiomed.com/u-s-fda-grants-birchbiomed-orphan-drug-designation-for-fs2-in-the-treatment-of-idiopathic-pulmonary-fibrosis/2026-01-23T10:10:21-05:00https://birchbiomed.com/birchbiomed-receives-health-canada-approval-for-topical-cream-npn-80147114/2026-06-03T16:20:25-05:00